CLEVELAND, November 8 /PRNewswire/ -- After extensive review, the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) and the Fundamentals of Endoscopic Surgery (FES) task force has selected Simbionix to collaboratively develop a simulation-based endoscopic hands-on skills assessment system.

One of the major challenges in training physicians to perform flexible endoscopy is the need for a standardized and efficient assessment tool to verify proficiency and identify deficiencies in a trainee's skills. In response to this concern, SAGES formed a committee to design a Fundamentals of Endoscopic Surgery (FES) Program. To address the requirements of the program, both multimedia and simulation-based educational elements need to be included, followed by a high-stakes validated exam to assess both knowledge and hands-on proficiency.

Simbionix' sophisticated GI Mentor technology platform will be used to develop the hands-on endoscopic simulation component specified by the FES Program. The hands-on component will feature skills training on the basic tasks needed for flexible endoscopy.

Gary Zamler, Simbionix' CEO, noted that, "This is clearly evidence of Simbionix leading position in the medical education market; we see this as a landmark step in the maturing of the medical simulation market. Simbionix appreciates the involvement of SAGES, a leading professional association, to advance the field of medical education through simulation-based programs for its membership. Simbionix is committed to this exciting and innovative project."

About Simbionix USA Corporation

Simbionix is the industry leader in the development of innovative and effective medical simulation products used for clinical education and training of medical professionals. Simbionix products are designed to accelerate best-practice medical training, advance clinical performance and improve patient safety. The company is committed to continuously innovating and broadening its product offerings with a wide range of training modules, case studies and scenarios, developed in response to the growing importance of clinical training and education as a means of achieving improved patient care.

Additional company information can be found at http://www.simbionix.com

Contact: Inbal Mazor VP Marketing Simbionix Tel: +1-216-229-2040 Email: Inbal@simbionix.com

Contact: Inbal Mazor, VP Marketing, Simbionix, Tel: +1-216-229-2040, Email: Inbal@simbionix.com